34176-17-5Relevant articles and documents
Structure Optimization of Gatastatin for the Development of γ-Tubulin-Specific Inhibitor
Chinen, Takumi,Ebisu, Haruna,Hatanaka, Taisei,Hayakawa, Ichiro,Mukaiyama, Minagi,Nagumo, Yoko,Sakakura, Akira,Shintani, Kana,Takao, Daisuke,Usui, Takeo
supporting information, p. 1125 - 1129 (2020/07/04)
Gatastatin (O7-benzyl glaziovianin A) is a γ-tubulin-specific inhibitor that is used to investigate γ-tubulin function in cells. We have previously reported that the unsubstituted phenyl ring of the O7-benzyl group in gatastatin is important for γ-tubulin
2-OXO-5H-CHROMENO[4,3-B]PYRIDINES FOR USE IN THE TREATMENT OF HEPATITIS B
-
, (2019/06/23)
The present invention discloses compounds according to Formula (I), wherein R1, R2a, R2b, R3, R4, and R5 are as defined herein. The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving hepatitis B by administering the compound of the invention.
Structure-activity requirements for flavone cytotoxicity and binding to tubulin
Beutler, John A.,Hamel, Ernest,Vlietinck, Arnold J.,Haemers, Achiel,Rajan, Padinchare,Roitman, James N.,Cardellina II, John H.,Boyd, Michael R.
, p. 2333 - 2338 (2007/10/03)
A series of 79 flavones related to centaureidin (3,6,4'-trimethoxy- 5,7,3'-trihydroxyflavone, 1) was screened for cytotoxicity in the NCI in vitro 60-cell line human tumor screen. The resulting cytotoxicity profiles of these flavones were compared for deg